Comparison of High-Dose Rosuvastatin Versus Low-Dose Rosuvastatin Plus Ezetimibe on Carotid Atherosclerotic Plaque Inflammation in Patients with Acute Coronary Syndrome

Minyoung Oh, Hyunji Kim, Eon Woo Shin, Changhwan Sung, Do Hoon Kim, Dae Hyuk Moon, Nayoung Kim, Jae Seon Eo, Jin Won Kim, Cheol Whan Lee

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

We compared the effects of ezetimibe/rosuvastatin 10/5 mg versus rosuvastatin 20 mg on carotid atherosclerotic plaque inflammation measured by 18FDG PET/CT. Fifty patients with acute coronary syndrome (ACS) were randomly assigned to the ezetimibe/rosuvastatin 10/5 mg and rosuvastatin 20 mg groups. The primary outcome was the percent change in the target-to-background ratio (TBR) of the index vessel in the most diseased segment (MDS), as assessed by 18FDG PET/CT at baseline and at 6 months. Forty-eight patients completed follow-up PET/CT. MDS TBR was − 6.2 ± 13.9% for patients in the ezetimibe/rosuvastatin group and − 10.8 ± 17.7% for those in the rosuvastatin group (difference, 4.6 percentage points; upper limitation of one-sided confidence interval = 13.8; p = 0.60 for noninferiority). In conclusion, combination therapy with ezetimibe 10 mg and rosuvastatin 5 mg compared with rosuvastatin 20 mg did not meet the criterion for non-inferiority for primary outcome, and the present study was not conclusive on whether the former was non-inferior to the latter. [Figure not available: see fulltext.].

Original languageEnglish
Pages (from-to)900-907
Number of pages8
JournalJournal of Cardiovascular Translational Research
Volume13
Issue number6
DOIs
Publication statusPublished - 2020 Dec
Externally publishedYes

Keywords

  • Ezetimibe
  • Plaque inflammation
  • Positron emission tomography
  • Statin

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Pharmaceutical Science
  • Cardiology and Cardiovascular Medicine
  • Genetics(clinical)

Fingerprint

Dive into the research topics of 'Comparison of High-Dose Rosuvastatin Versus Low-Dose Rosuvastatin Plus Ezetimibe on Carotid Atherosclerotic Plaque Inflammation in Patients with Acute Coronary Syndrome'. Together they form a unique fingerprint.

Cite this